Bronchopulmonary dysplasia

7 trials 4 recruiting MedDRA PT
7 Registered trials
4 Recruiting
7 Unique sponsors
7 Unique IMPs
3 Commercial trials
Drug classes (ATC)
R Respiratory (ATC R) 2
— ATC code not specified 4
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Supportive / diluent 1 substance
Corticosteroid 1 substance
Phase III: 2 Phase II/III: 1 Phase II: 2 Phase IV: 1 Phase I (First in Human): 1

Filter these 7 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 7 trials

Phase III

2 trials
  • Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer Academic
    BUDESONIDE; PORACTANT ALFA
    2024-519980-16-00 1 country n=60
    Ended
  • Universitaetsklinikum Tuebingen AöR Academic
    IMP not specified
    2024-511335-10-01 1 country 2018 n=865
    Ended

Phase II/III

1 trial
  • Airway Therapeutics Inc. Commercial
    RECOMBINANT HUMAN SURFACTANT PROTEIN-D
    2024-513420-41-00 6 countries 2025 n=241 Orphan
    Recruiting

Phase II

2 trials
  • Aspire Pharma Limited Commercial
    RETINOL PALMITATE
    2024-516994-59-00 2 countries 2026 n=20 Orphan
    Ended
  • Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal Academic
    MESENCHYMAL CELLS
    2024-516677-79-00 1 country 2024 n=75
    Recruiting

Phase IV

1 trial
  • Semmelweis University Academic
    IMP not specified
    2024-519041-29-02 1 country 2025 n=226
    Recruiting

Phase I (First in Human)

1 trial
  • Exo Biologics Commercial
    ALLOGENEIC UMBILICAL CORD MESENCHYMAL CELLS-DERIVED EXTRACELLULAR VESICLES; SODIUM CHLORIDE
    2022-500293-34-01 2 countries 2023 n=265 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Airway Therapeutics Inc. Commercial 1 Phase II/III 1
Aspire Pharma Limited Commercial 1 Phase II 0
Exo Biologics Commercial 1 Phase I (First in Human) 1
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal Academic 1 Phase II 1
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer Academic 1 Phase III 0
Universitaetsklinikum Tuebingen AöR Academic 1 Phase III 0
Semmelweis University Academic 1 Phase IV 1
New trials by year
2023
1
2024
1
2025
2
2026
1
← All indication landscapes